These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 28162931)

  • 21. Comparison of a home-based (multi) systemic intervention to promoting Medication AdheRence and Self-management among kidney transplant recipients with care-as-usual: the MARS randomized controlled trial protocol.
    Beck DK; Tielen M; Rechards M; Timman R; Boonstra C; Versteegh J; van de Wetering J; Zietse R; van Gelder T; Weimar W; van Saase J; van Busschbach J; Massey EK
    BMC Nephrol; 2020 Aug; 21(1):374. PubMed ID: 32859157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adherence to Immunosuppressive Medication in Renal Transplant Recipients From Follow-up Outpatient in China: Association of 2 Different Measurement Methods.
    Liu J; Liu S; Yan J; Yi Q; Huang H
    Clin Ther; 2015 Nov; 37(11):2572-80. PubMed ID: 26519232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence to and Acceptance of Once-Daily Tacrolimus After Kidney and Liver Transplant: Results From OSIRIS, a French Observational Study.
    Cassuto E; Pageaux GP; Cantarovich D; Rostaing L; Loupy A; Roche B; Duvoux C; Moreau K; Thervet E; Mazouz H; Bourhis Y; Dharancy S; Kessler M;
    Transplantation; 2016 Oct; 100(10):2099-2106. PubMed ID: 27653227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial.
    Zuckermann A; Reichenspurner H; Birsan T; Treede H; Deviatko E; Reichart B; Klepetko W
    J Thorac Cardiovasc Surg; 2003 Apr; 125(4):891-900. PubMed ID: 12698153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation.
    Song JL; Gao W; Zhong Y; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG; Jiang L; Yang J
    World J Gastroenterol; 2016 Feb; 22(6):2133-41. PubMed ID: 26877618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study.
    Fischer L; Saliba F; Kaiser GM; De Carlis L; Metselaar HJ; De Simone P; Duvoux C; Nevens F; Fung JJ; Dong G; Rauer B; Junge G;
    Transplantation; 2015 Jul; 99(7):1455-62. PubMed ID: 26151607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Automated Reminders and Physician Notification to Promote Immunosuppression Adherence Among Kidney Transplant Recipients: A Randomized Trial.
    Reese PP; Bloom RD; Trofe-Clark J; Mussell A; Leidy D; Levsky S; Zhu J; Yang L; Wang W; Troxel A; Feldman HI; Volpp K
    Am J Kidney Dis; 2017 Mar; 69(3):400-409. PubMed ID: 27940063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of prophylactic use of sirolimus on bronchiolitis obliterans syndrome development in lung transplant recipients.
    Sacher VY; Fertel D; Srivastava K; Panos A; Nguyen D; Baxter T; Shafazand S; Pham SM
    Ann Thorac Surg; 2014 Jan; 97(1):268-74. PubMed ID: 24119986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes in pediatric solid-organ transplantation.
    LaRosa C; Baluarte HJ; Meyers KE
    Pediatr Transplant; 2011 Mar; 15(2):128-41. PubMed ID: 21309962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients.
    Hatakeyama S; Fujita T; Yoneyama T; Yoneyama T; Koie T; Hashimoto Y; Saitoh H; Funyu T; Narumi S; Ohyama C
    Transplant Proc; 2012 Jan; 44(1):121-3. PubMed ID: 22310594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The spectrum of nonadherence with medication in heart, liver, and lung transplant patients assessed in various ways.
    De Bleser L; Dobbels F; Berben L; Vanhaecke J; Verleden G; Nevens F; De Geest S
    Transpl Int; 2011 Sep; 24(9):882-91. PubMed ID: 21740471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective, randomized trial of single-drug versus dual-drug immunosuppression in heart transplantation: the tacrolimus in combination, tacrolimus alone compared (TICTAC) trial.
    Baran DA; Zucker MJ; Arroyo LH; Camacho M; Goldschmidt ME; Nicholls SJ; Prevost-Fernandez J; Carr C; Adams L; Pardi S; Hou V; Binetti M; McCahill J; Chichetti J; Viloria V; Sanagustin MG; Ebuenga-Smith J; Mele L; Martin A; Blicharz D; Wolski K; Olesnicky L; Qian F; Gass AL; Cohen M
    Circ Heart Fail; 2011 Mar; 4(2):129-37. PubMed ID: 21216835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corticosteroid-Sparing and Optimization of Mycophenolic Acid Exposure in Liver Transplant Recipients Receiving Mycophenolate Mofetil and Tacrolimus: A Randomized, Multicenter Study.
    Saliba F; Rostaing L; Gugenheim J; Durand F; Radenne S; Leroy V; Neau-Cransac M; Calmus Y; Salamé E; Pageaux GP; Duvoux C; Taguieva N; Sinnasse-Raymond G; Sebagh M; Samuel D; Marquet P
    Transplantation; 2016 Aug; 100(8):1705-13. PubMed ID: 27454919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-reported non-adherence to immunosuppressive medication in adult lung transplant recipients-A single-center cross-sectional study.
    Drick N; Seeliger B; Fuge J; Tudorache I; Greer M; Welte T; Haverich A; Gottlieb J
    Clin Transplant; 2018 Apr; 32(4):e13214. PubMed ID: 29380445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of low-dose valganciclovir in the prevention of cytomegalovirus disease in adult liver transplant recipients.
    Park JM; Lake KD; Arenas JD; Fontana RJ
    Liver Transpl; 2006 Jan; 12(1):112-6. PubMed ID: 16382458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cost effectiveness of tacrolimus versus microemulsified cyclosporin: a 10-year model of renal transplantation outcomes.
    Orme ME; Jurewicz WA; Kumar N; McKechnie TL
    Pharmacoeconomics; 2003; 21(17):1263-76. PubMed ID: 14986738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lower tacrolimus trough levels in the late period after living donor liver transplantation contribute to improvements in long-term clinical outcomes.
    Geng L; Wang LD; Huang JJ; Shen T; Wang ZY; Lin BY; Ye YF; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):204-209. PubMed ID: 29807766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative introduction and maintenance immunosuppression therapy of oral-only tacrolimus, mycophenolate mofetil and steroids reduce acute rejection episodes after lung transplantation.
    Bittner HB; Barten MJ; Binner C; Lehmann S; Garbade J; Hammerschmidt S; Wirtz H; Mohr FW
    Eur J Cardiothorac Surg; 2010 Sep; 38(3):268-76. PubMed ID: 20304665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do empowered stroke patients perform better at self-management and functional recovery after a stroke? A randomized controlled trial.
    Sit JW; Chair SY; Choi KC; Chan CW; Lee DT; Chan AW; Cheung JL; Tang SW; Chan PS; Taylor-Piliae RE
    Clin Interv Aging; 2016; 11():1441-1450. PubMed ID: 27789938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adherence to immunosuppression in adult lung transplant recipients: prevalence and risk factors.
    Bosma OH; Vermeulen KM; Verschuuren EA; Erasmus ME; van der Bij W
    J Heart Lung Transplant; 2011 Nov; 30(11):1275-80. PubMed ID: 21724418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.